October 25, 2016 / 9:22 PM / in a year

BRIEF-OncoGenex announces positive survival results from apatorsen Phase 2 trial in metatstatic bladder cancer

Oct 25 (Reuters) - Oncogenex Pharmaceuticals Inc :

* OncoGenex announces positive survival results from apatorsen Phase 2 Borealis-2 trial in metastatic bladder cancer

* OncoGenex -safety results in patients treated with apatorsen and docetaxel were similar to those observed in patients treated with docetaxel alone Source text for Eikon: Further company coverage: ;))

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below